Table 2

Poisson regression evaluating the influence of any antibacterial prophylaxis (N = 115) or penicillin/vancomycin prophylaxis (N = 70)

InfectionNAny antibacterial prophylaxis
Penicillin or vancomycin prophylaxis
IRR (95% CI)PAdjusted IRR* (95% CI)Adjusted P*IRRPAdjusted IRR* (95% CI)Adjusted P*
Any sterile-site bacterial infection 612 0.84 (0.71-0.98) .028 0.85 (0.72-1.01) .058 0.87 (0.72-1.05) .150 0.92 (0.75-1.12) .398 
Gram-positive sterile-site bacterial infection 512 0.72 (0.58-0.90) .004 0.71 (0.57-0.90) .004 0.73 (0.56-0.95) .021 0.76 (0.58-1.01) .054 
Gram-negative sterile-site bacterial infection 78 1.39 (0.78-2.47) .258 1.39 (0.75-2.60) .297 1.03 (0.48-2.23) .940 1.07 (0.46-2.48) .872 
C difficile infection 123 0.77 (0.46-1.30) .330 0.65 (0.38-1.13) .126 1.09 (0.63-1.88) .769 0.88 (0.48-1.59) .674 
Sterile-site fungal infection 49 1.07 (0.49-2.38) .860 1.11 (0.47-2.63) .812 1.47 (0.63-3.43) .378 1.50 (0.59-3.81) .399 
InfectionNAny antibacterial prophylaxis
Penicillin or vancomycin prophylaxis
IRR (95% CI)PAdjusted IRR* (95% CI)Adjusted P*IRRPAdjusted IRR* (95% CI)Adjusted P*
Any sterile-site bacterial infection 612 0.84 (0.71-0.98) .028 0.85 (0.72-1.01) .058 0.87 (0.72-1.05) .150 0.92 (0.75-1.12) .398 
Gram-positive sterile-site bacterial infection 512 0.72 (0.58-0.90) .004 0.71 (0.57-0.90) .004 0.73 (0.56-0.95) .021 0.76 (0.58-1.01) .054 
Gram-negative sterile-site bacterial infection 78 1.39 (0.78-2.47) .258 1.39 (0.75-2.60) .297 1.03 (0.48-2.23) .940 1.07 (0.46-2.48) .872 
C difficile infection 123 0.77 (0.46-1.30) .330 0.65 (0.38-1.13) .126 1.09 (0.63-1.88) .769 0.88 (0.48-1.59) .674 
Sterile-site fungal infection 49 1.07 (0.49-2.38) .860 1.11 (0.47-2.63) .812 1.47 (0.63-3.43) .378 1.50 (0.59-3.81) .399 
*

Analysis adjusted for age, race, and weight group.

Close Modal

or Create an Account

Close Modal
Close Modal